loader
Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Am-Fam 400

Menu
$ API Ref.Price (USD/KG) : 12Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AFT PHARMS LTD

02 14CUMBERLAND PHARMS

03 4HALEON US HOLDINGS

04 5HORIZON

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 11534407

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-02-27

blank

02

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 11197830

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-02-27

blank

03

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 10532036

Drug Substance Claim :

Drug Product Claim :

Application Number : 209471

Patent Use Code : U-3553

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-09-22

blank

04

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 9114068

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-1735

Delist Requested :

Patent Use Description : METHODS OF TREATING PA...

Patent Expiration Date : 2029-09-30

blank

05

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 8735452

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-981

Delist Requested :

Patent Use Description : MANAGEMENT OF MILD TO ...

Patent Expiration Date : 2029-09-30

blank

06

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 9649284

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-2018

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-09-30

blank

07

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 9012508

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-981

Delist Requested :

Patent Use Description : MANAGEMENT OF MILD TO ...

Patent Expiration Date : 2030-09-14

blank

08

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 9072661

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-2264

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-03-16

blank

09

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 8871810

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-981

Delist Requested :

Patent Use Description : MANAGEMENT OF MILD TO ...

Patent Expiration Date : 2029-09-30

blank

10

arrow
Boulder Peptide 2024
Not Confirmed
arrow
Boulder Peptide 2024
Not Confirmed

IBUPROFEN

US Patent Number : 9012508

Drug Substance Claim :

Drug Product Claim :

Application Number : 22348

Patent Use Code : U-981

Delist Requested :

Patent Use Description : MANAGEMENT OF MILD TO ...

Patent Expiration Date : 2030-09-14

blank